Legal Opinion
In Re Lupron Marketing and Sales Practices Litigation
District Court, D. Massachusetts
Decided February 19, 2003No. MDL 1430, 01-CV-10861-RGSPublishedCited by 28 opinions
1Opinion of the Court
MEMORANDUM AND ORDER ON DEFENDANT TAKEDA’S MOTION TO DISMISS FOR WANT OF PERSONAL JURISDICTION
STEARNS, District Judge.
A consortium of patients and health care plans maintains that defendants Abbott Laboratories (“Abbott”), Takeda Chemical Industries, Ltd. (“Takeda”) and TAP Pharmaceutical Products, Inc. (“TAP”) (an Illinois corporation owned by Abbott and Takeda) conspired to artificially inflate the price for the cancer drug Lupron®. 1 The plaintiffs’ consolidated class action is grounded on the civil provisions of the Racketeer Influenced and Corrupt Organizations Act (“RICO”), 18 U.S.C. §…
2Cases cited77 opinions
- International Shoe Co. v. WashingtonSupreme Court of the United States · 1945
- Burger King Corp. v. RudzewiczSupreme Court of the United States · 1985
- Steel Co. v. Citizens for a Better EnvironmentSupreme Court of the United States · 1998
- World-Wide Volkswagen Corp. v. WoodsonSupreme Court of the United States · 1980
- Helicopteros Nacionales De Colombia, S. A. v. HallSupreme Court of the United States · 1984
72 more not listed; retrieve them via the Exa API.
3Cited by28 opinions
- Daventree Ltd. v. Republic of AzerbaijanDistrict Court, S.D. New York · 2004
- In Re Lupron® Marketing & Sales Practices LitigationDistrict Court, D. Massachusetts · 2003
- Commonwealth Ex Rel. Pappert v. TAP Pharmaceutical Products, Inc.Commonwealth Court of Pennsylvania · 2005
- In re Lupron Marketing & Sales Practices LitigationDistrict Court, D. Massachusetts · 2005
- In Re Lupron Marketing and Sales Practices Litig.Court of Appeals for the First Circuit · 2012
23 more not listed; retrieve them via the Exa API.